title: Bmf contributes to histone deacetylase inhibitor-mediated enhancing effects on apoptosis after ionizing radiation.
abstract: Histone deacetylase (HDAC) inhibitors augment ionizing radiation (IR)-induced apoptosis in several cancer cells by undefined mechanism(s). We recently found that the HDAC inhibitors induce a BH3-only protein Bmf in human squamous carcinoma SAS cells. We extended this study and found that 2.5 nM FK228 pretreatment could not induce apoptosis but augmented IR-induced death. The FK228 pretreatment increased Bmf expression level, and siRNA-mediated knockdown of Bmf transcripts strongly inhibited its augmentation of IR-induced cell death, disruption of mitochondrial membrane potential and DNA fragmentation. Another HDAC inhibitor CBHA pretreatment similarly augmented IR-induced apoptosis, and this effect was also inhibited by Bmf knockdown. Bmf overexpression augmented IR-induced death, and the augmented effects of FK228 were similarly observed in another squamous carcinoma HSC2 cells. Overexpression of histone acetyltransferase p300 mimicked the effects of the HDAC inhibitors, i.e., it enhanced IR-induced death, which was mostly abolished by Bmf knockdown. Taken together, histone hyperacetylation may enhance IR-induced death via activation of Bmf transcription, thereby implying Bmf as a key molecule for HDAC inhibitors (FK228 and CBHA)-mediated enhancing effect on IR-induced cell death.
authors.affiliation: First Department of Internal Medicine, Sapporo Medical University School of Medicine, S-1 W-16 Chuo-ku, Sapporo 060-8543, Japan.
authors.forename: Yubin
authors.initials: Y
authors.lastname: Zhang
authors.forename: Masaaki
authors.initials: M
authors.lastname: Adachi
authors.forename: Rina
authors.initials: R
authors.lastname: Kawamura
authors.forename: Hui Chao
authors.initials: HC
authors.lastname: Zou
authors.forename: Kohzoh
authors.initials: K
authors.lastname: Imai
authors.forename: Masato
authors.initials: M
authors.lastname: Hareyama
authors.forename: Yasuhisa
authors.initials: Y
authors.lastname: Shinomura
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000502:physiology*; D017209:Apoptosis / Q000187:drug effects* / Q000528:radiation effects; D018797:Cell Cycle Proteins / Q000378:metabolism; D002934:Cinnamates / Q000494:pharmacology; D002945:Cisplatin / Q000494:pharmacology; D047630:Depsipeptides / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D051548:Histone Acetyltransferases / Q000378:metabolism; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D007259:Infrared Rays; D034741:RNA, Small Interfering / Q000378:metabolism; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*; D014157:Transcription Factors / Q000378:metabolism; D014407:Tumor Cells, Cultured; D014965:X-Rays; D050880:p300-CBP Transcription Factors; D000099224:p300-CBP-Associated Factor
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D018797:Cell Cycle Proteins; D002934:Cinnamates; D002945:Cisplatin; D047630:Depsipeptides; D004791:Enzyme Inhibitors; D051548:Histone Acetyltransferases; D056572:Histone Deacetylase Inhibitors; D034741:RNA, Small Interfering; D011838:Radiation-Sensitizing Agents; D014157:Transcription Factors; D050880:p300-CBP Transcription Factors; D000099224:p300-CBP-Associated Factor; C486655:BMF protein, human; C111238:carboxycinnamic acid bishydroxamide; C087123:romidepsin